TABLE 4.
Summary of FKS alterations detected among Candida isolates displaying echinocandin MIC values above the ECV
| Country or U.S. state | Organism | MIC (μg/ml) by CLSI methoda |
1,3-β-d-Glucan synthase mutationsb |
|||||
|---|---|---|---|---|---|---|---|---|
| Anidulafungin | Caspofungin | Micafungin | FKS1 HS1 | FKS1 HS2 | FKS2 HS1 | FKS2 HS2 | ||
| Italy | Candida albicans | 0.12 | 0.12 | 0.06 (>ECV) | WT | WT | NT | NT |
| New York | Candida albicans | 0.25 | 1 (R) | 1 (R) | S645P | WT | NT | NT |
| Indiana | Candida albicans | 0.5 | 1 (R) | 1 (R) | S645P | WT | NT | NT |
| New York | Candida glabrata | 0.25 | 0.5 (R) | 0.03 | WT | WT | P667T | NT |
| New York | Candida glabrata | 0.5 (R) | 0.25 | 0.25 (R) | WT | WT | S663P | WT |
| Slovenia | Candida glabrata | 0.5 (R) | 0.25 | 0.06 (>ECV) | WT | WT | WT | WT |
| Colorado | Candida glabrata | 0.25 | 0.12 | 0.06 (>ECV) | WT | WT | WT | WT |
| Indiana | Candida glabrata | 2 (R) | 2 (R) | 0.5 (R) | F625S | WT | F659Y | WT |
| Israel | Candida glabrata | 2 (R) | 2 (R) | 2 (R) | WT | WT | F659S | WT |
| California | Candida glabrata | 2 (R) | 8 (R) | 2 (R) | S629P | WT | WT | WT |
| California | Candida glabrata | 0.25 | 0.5 (R) | 0.25 (R) | WT | WT | F659S | WT |
| Australia | Candida glabrata | 0.06 | 0.5 (R) | 0.015 | WT | WT | WT | WT |
| New York | Candida glabrata | 2 (R) | 2 (R) | 2 (R) | WT | WT | S663P | WT |
| Canada | Candida glabrata | 4 (R) | >8 (R) | 4 (R) | S629P | WT | S663P | WT |
| Canada | Candida glabrata | 4 (R) | >8 (R) | 4 (R) | S629P | WT | S663P | WT |
| Georgia | Candida glabrata | 2 (R) | 2 (R) | 0.5 (R) | F625S | WT | WT | WT |
| California | Candida glabrata | 1 (R) | 1 (R) | 0.25 (R) | F625S | WT | WT | WT |
| Colorado | Candida glabrata | 0.5 (R) | 0.25 | 0.03 | WT | WT | WT | WT |
| Virginia | Candida glabrata | 0.12 | 0.06 | 0.12 (>ECV) | WT | WT | WT | WT |
| Turkey | Candida tropicalis | 0.06 | 0.06 | 0.12 (>ECV) | WT | WT | NT | NT |